# Callisto

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/callisto

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: www.callisto-ai.com
- Total disclosed funding: $1.5M
- Latest round: Seed (Apr 10, 2023)
- Investors on record: 2

## About

Based in Tokyo, Japan, and founded in 2022, Callisto Inc operates as a health technology company that uses artificial intelligence and manufactures pharmaceuticals and medical equipment. In April 2023, Callisto Inc. raised JPY 200 million in seed funding led by ITOCHU Technology Ventures and NOW (Japan). As of 2023, the company is led by its CEO Han Chang-hee.

The company offers a technology-based platform that compiles medical picture data for the research and development of healthcare Artificial Intelligence. Additionally, the company develops Artificial Intelligence solutions for manufacturers of pharmaceuticals and medical equipment. The platform offers data set copyrights and the artificial intelligence data offered by the firm could be used by pharmaceutical companies, medical device manufacturers, AI companies, etc. It also pays the authors for their data usage.

The company plans to use the April 2023 funding to develop custom drug discovery using Artificial Intelligence, as well as a data platform for healthcare.

## Funding rounds

- Seed, Apr 10, 2023, $1.5M — ITOCHU Technology Ventures, NOW (Japan)

## Investors

- ITOCHU Technology Ventures (https://capitalatlas.ai/funds/itochu-technology-ventures) — Seed
- NOW (Japan) — Seed